Nature Communications (Oct 2024)
Rare variant contribution to the heritability of coronary artery disease
- Ghislain Rocheleau,
- Shoa L. Clarke,
- Gaëlle Auguste,
- Natalie R. Hasbani,
- Alanna C. Morrison,
- Adam S. Heath,
- Lawrence F. Bielak,
- Kruthika R. Iyer,
- Erica P. Young,
- Nathan O. Stitziel,
- Goo Jun,
- Cecelia Laurie,
- Jai G. Broome,
- Alyna T. Khan,
- Donna K. Arnett,
- Lewis C. Becker,
- Joshua C. Bis,
- Eric Boerwinkle,
- Donald W. Bowden,
- April P. Carson,
- Patrick T. Ellinor,
- Myriam Fornage,
- Nora Franceschini,
- Barry I. Freedman,
- Nancy L. Heard-Costa,
- Lifang Hou,
- Yii-Der Ida Chen,
- Eimear E. Kenny,
- Charles Kooperberg,
- Brian G. Kral,
- Ruth J. F. Loos,
- Sharon M. Lutz,
- JoAnn E. Manson,
- Lisa W. Martin,
- Braxton D. Mitchell,
- Rami Nassir,
- Nicholette D. Palmer,
- Wendy S. Post,
- Michael H. Preuss,
- Bruce M. Psaty,
- Laura M. Raffield,
- Elizabeth A. Regan,
- Stephen S. Rich,
- Jennifer A. Smith,
- Kent D. Taylor,
- Lisa R. Yanek,
- Kendra A. Young,
- NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium,
- Austin T. Hilliard,
- Catherine Tcheandjieu,
- Patricia A. Peyser,
- Ramachandran S. Vasan,
- Jerome I. Rotter,
- Clint L. Miller,
- Themistocles L. Assimes,
- Paul S. de Vries,
- Ron Do
Affiliations
- Ghislain Rocheleau
- The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai
- Shoa L. Clarke
- Department of Medicine, Stanford Prevention Research Center, Stanford University School of Medicine
- Gaëlle Auguste
- Center for Public Health Genomics, University of Virginia
- Natalie R. Hasbani
- Department of Epidemiology, Human Genetics, and Environmental Sciences, Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston
- Alanna C. Morrison
- Department of Epidemiology, Human Genetics, and Environmental Sciences, Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston
- Adam S. Heath
- Department of Epidemiology, Human Genetics, and Environmental Sciences, Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston
- Lawrence F. Bielak
- Department of Epidemiology, School of Public Health, University of Michigan
- Kruthika R. Iyer
- Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine
- Erica P. Young
- Department of Medicine, Division of Cardiology, Washington University School of Medicine
- Nathan O. Stitziel
- Department of Medicine, Division of Cardiology, Washington University School of Medicine
- Goo Jun
- Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston
- Cecelia Laurie
- Department of Biostatistics, University of Washington
- Jai G. Broome
- Department of Biostatistics, University of Washington
- Alyna T. Khan
- Department of Biostatistics, University of Washington
- Donna K. Arnett
- College of Public Health, University of Kentucky
- Lewis C. Becker
- GeneSTAR Research Program, Department of Medicine, Johns Hopkins University School of Medicine
- Joshua C. Bis
- Department of Medicine, Cardiovascular Health Research Unit, University of Washington
- Eric Boerwinkle
- Department of Epidemiology, Human Genetics, and Environmental Sciences, Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston
- Donald W. Bowden
- Department of Biochemistry, Wake Forest University School of Medicine
- April P. Carson
- Department of Medicine, University of Mississippi Medical Center
- Patrick T. Ellinor
- Cardiovascular Research Center, Massachusetts General Hospital
- Myriam Fornage
- Department of Epidemiology, Human Genetics, and Environmental Sciences, Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston
- Nora Franceschini
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina
- Barry I. Freedman
- Department of Internal Medicine, Section on Nephrology, Wake Forest University School of Medicine
- Nancy L. Heard-Costa
- National Heart, Lung, and Blood Institute and Boston University’s Framingham Heart Study
- Lifang Hou
- Department of Preventive Medicine, Northwestern University Feinberg School of Medicine
- Yii-Der Ida Chen
- Department of Pediatrics, The Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Eimear E. Kenny
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai
- Charles Kooperberg
- Division of Public Health Sciences, Fred Hutchinson Cancer Center
- Brian G. Kral
- GeneSTAR Research Program, Department of Medicine, Johns Hopkins University School of Medicine
- Ruth J. F. Loos
- The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai
- Sharon M. Lutz
- Department of Population Medicine, Harvard Pilgrim Health Care
- JoAnn E. Manson
- Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
- Lisa W. Martin
- School of Medicine and Health Sciences, George Washington University
- Braxton D. Mitchell
- Department of Medicine, University of Maryland School of Medicine
- Rami Nassir
- Department of Pathology, School of Medicine, Umm Al-Qura University
- Nicholette D. Palmer
- Department of Biochemistry, Wake Forest University School of Medicine
- Wendy S. Post
- Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University School of Medicine
- Michael H. Preuss
- The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai
- Bruce M. Psaty
- Department of Medicine, Cardiovascular Health Research Unit, University of Washington
- Laura M. Raffield
- Department of Genetics, University of North Carolina at Chapel Hill
- Elizabeth A. Regan
- Department of Medicine, Division of Rheumatology, National Jewish Health
- Stephen S. Rich
- Center for Public Health Genomics, University of Virginia
- Jennifer A. Smith
- Department of Epidemiology, School of Public Health, University of Michigan
- Kent D. Taylor
- Department of Pediatrics, The Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Lisa R. Yanek
- GeneSTAR Research Program, Department of Medicine, Johns Hopkins University School of Medicine
- Kendra A. Young
- Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus
- NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium
- Austin T. Hilliard
- VA Palo Alto Health Care System
- Catherine Tcheandjieu
- Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine
- Patricia A. Peyser
- Department of Epidemiology, School of Public Health, University of Michigan
- Ramachandran S. Vasan
- National Heart, Lung, and Blood Institute and Boston University’s Framingham Heart Study
- Jerome I. Rotter
- Department of Pediatrics, The Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Clint L. Miller
- Center for Public Health Genomics, University of Virginia
- Themistocles L. Assimes
- Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine
- Paul S. de Vries
- Department of Epidemiology, Human Genetics, and Environmental Sciences, Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston
- Ron Do
- The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai
- DOI
- https://doi.org/10.1038/s41467-024-52939-6
- Journal volume & issue
-
Vol. 15,
no. 1
pp. 1 – 13
Abstract
Abstract Whole genome sequences (WGS) enable discovery of rare variants which may contribute to missing heritability of coronary artery disease (CAD). To measure their contribution, we apply the GREML-LDMS-I approach to WGS of 4949 cases and 17,494 controls of European ancestry from the NHLBI TOPMed program. We estimate CAD heritability at 34.3% assuming a prevalence of 8.2%. Ultra-rare (minor allele frequency ≤ 0.1%) variants with low linkage disequilibrium (LD) score contribute ~50% of the heritability. We also investigate CAD heritability enrichment using a diverse set of functional annotations: i) constraint; ii) predicted protein-altering impact; iii) cis-regulatory elements from a cell-specific chromatin atlas of the human coronary; and iv) annotation principal components representing a wide range of functional processes. We observe marked enrichment of CAD heritability for most functional annotations. These results reveal the predominant role of ultra-rare variants in low LD on the heritability of CAD. Moreover, they highlight several functional processes including cell type-specific regulatory mechanisms as key drivers of CAD genetic risk.